Mei Pharma Stock Predictions

Healthcare > Biotechnology

Buy MEIP

*Your capital is at risk

$3.07

+0 (+0%)

At Close: Dec 09, 2025

Currently predicting for Fri, 26 Jun 2026

MEIP Live board

Community Bull/Bear

Target Next close

Join the MEIP prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

MEIP Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For MEIP

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

MEIP Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT MEI PHARMA

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cycl...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
NESR $25.06	0.439%	Jun 22
IDYA $28.98	25.19%	Jun 12
PHM $118.49	14.53%	Jun 10
DHI $146.71	13.50%	Jun 10
EAT $140.46	20.94%	Jun 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by